Related Experiment Video
Updated: Sep 4, 2025
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Graves' disease: moving forwards
Laura C Lane1,2, Claire Louise Wood1,2, Tim Cheetham3,2
1Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Abstract:
Graves' disease is a rare disorder that continues to present clinicians and families with a series of challenges. There are no new established treatments for children or adolescents, but the outcomes of recent clinical trials and meta-analyses have helped clinicians to prepare families for the road ahead. We have a more refined understanding of how to administer antithyroid drugs, which one to use and how long to treat the young person. We also have a greater insight into how best to reduce any risks associated with surgery and radioiodine. We understand more about long-term outcomes and their determinants and have greater awareness about the impact of the disease and its treatment on quality of life. A holistic approach to management is key to supporting and counselling young people and their families about the diagnosis and management options. In this review, we will discuss the recent literature and reflect on how this should be translated into clinical practice.
Insights
Recent advancements refine management of Graves' disease in pediatric patients, improving antithyroid drug use, surgical/radioiodine risk reduction, and long-term outcome understanding for better quality of life.
Area of Science:
- Pediatric Endocrinology
- Autoimmune Disorders
- Clinical Practice Guidelines
Background:
- Graves' disease presents significant challenges in pediatric populations.
- Established treatments for children and adolescents remain limited.
- Recent clinical trials and meta-analyses offer new insights.
Purpose of the Study:
- To review recent literature on Graves' disease management in young people.
- To provide guidance on optimizing treatment strategies.
- To enhance understanding of long-term outcomes and quality of life.
Main Methods:
- Review of recent clinical trials and meta-analyses.
- Analysis of data on antithyroid drug administration.
- Evaluation of risks associated with surgery and radioiodine therapy.
Main Results:
- Refined understanding of antithyroid drug selection and duration.
- Improved strategies for minimizing surgical and radioiodine risks.
- Greater insight into long-term outcomes and quality of life determinants.
Conclusions:
- A holistic management approach is crucial for supporting pediatric patients and families.
- Recent evidence should be translated into improved clinical practice.
- Enhanced understanding aids in counseling and decision-making for Graves' disease treatment.
More Related Videos
05:41Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
Published on: February 9, 2024
07:13Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
01:15Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:20Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...